Directional Asset Management Purchases Shares of 314,450 Option Care Health, Inc. $OPCH

Directional Asset Management purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 314,450 shares of the company’s stock, valued at approximately $10,018,000. Option Care Health comprises about 8.8% of Directional Asset Management’s portfolio, making the stock its largest holding.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Durable Capital Partners LP boosted its holdings in shares of Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the period. Swedbank AB bought a new stake in shares of Option Care Health in the third quarter worth about $49,455,000. UBS Group AG increased its holdings in Option Care Health by 250.2% during the 3rd quarter. UBS Group AG now owns 1,165,525 shares of the company’s stock valued at $32,355,000 after purchasing an additional 832,720 shares during the period. Alliancebernstein L.P. increased its holdings in Option Care Health by 113.6% during the 3rd quarter. Alliancebernstein L.P. now owns 1,298,691 shares of the company’s stock valued at $36,052,000 after purchasing an additional 690,572 shares during the period. Finally, Duquesne Family Office LLC bought a new position in Option Care Health during the 2nd quarter valued at approximately $20,685,000. 98.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on OPCH. Barrington Research increased their price objective on Option Care Health from $38.00 to $42.00 and gave the stock an “outperform” rating in a report on Friday, January 16th. Morgan Stanley upped their target price on Option Care Health from $35.00 to $38.00 and gave the company an “overweight” rating in a report on Tuesday, January 13th. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research note on Tuesday, January 13th. Wall Street Zen cut shares of Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. Finally, TD Cowen reissued a “hold” rating on shares of Option Care Health in a research report on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $37.27.

Option Care Health Trading Up 0.6%

Shares of NASDAQ OPCH opened at $28.54 on Friday. Option Care Health, Inc. has a 1 year low of $24.24 and a 1 year high of $36.80. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.53 and a quick ratio of 0.96. The firm has a 50-day moving average of $30.07 and a 200 day moving average of $30.72. The stock has a market cap of $4.48 billion, a P/E ratio of 22.30, a price-to-earnings-growth ratio of 1.59 and a beta of 0.95.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.46. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The business had revenue of $1.47 billion during the quarter, compared to the consensus estimate of $1.46 billion. During the same quarter last year, the firm earned $0.44 earnings per share. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. As a group, sell-side analysts expect that Option Care Health, Inc. will post 1.69 EPS for the current fiscal year.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.